- Forums
- ASX - By Stock
- TLX
- Ann: Overview of ProstACT Phase III Study - Investor supplement
Ann: Overview of ProstACT Phase III Study - Investor supplement, page-19
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$20.28 |
Change
0.645(3.29%) |
Mkt cap ! $6.711B |
Open | High | Low | Value | Volume |
$20.22 | $20.43 | $19.94 | $30.82M | 1.527M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 274 | $20.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.28 | 408 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 1155 | 20.250 |
8 | 1334 | 20.240 |
8 | 1275 | 20.230 |
8 | 980 | 20.220 |
5 | 547 | 20.210 |
Price($) | Vol. | No. |
---|---|---|
20.270 | 955 | 13 |
20.280 | 521 | 6 |
20.290 | 548 | 5 |
20.300 | 2230 | 10 |
20.310 | 2004 | 11 |
Last trade - 15.38pm 23/07/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online